Literature DB >> 9091795

Variable bioavailability of oral melatonin.

W L Di, A Kadva, A Johnston, R Silman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9091795     DOI： 10.1056/NEJM199704033361418

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  28 in total

Review 1.  Clinical pharmacokinetics of melatonin: a systematic review.

Authors:  Nathja Groth Harpsøe; Lars Peter Holst Andersen; Ismail Gögenur; Jacob Rosenberg
Journal:  Eur J Clin Pharmacol       Date:  2015-05-27       Impact factor: 2.953

2.  Melatonin in children with autism spectrum disorders: endogenous and pharmacokinetic profiles in relation to sleep.

Authors:  Suzanne E Goldman; Karen W Adkins; M Wade Calcutt; Melissa D Carter; Robert L Goodpaster; Lily Wang; Yaping Shi; Helen J Burgess; David L Hachey; Beth A Malow
Journal:  J Autism Dev Disord       Date:  2014-10

3.  The Role of Melatonin in Palliative Care #306.

Authors:  Georgina Waldman; Jennifer Pruskowski; Robert Arnold
Journal:  J Palliat Med       Date:  2016-04-20       Impact factor: 2.947

4.  Melatonin pharmacokinetics following two different oral surge-sustained release doses in older adults.

Authors:  Nalaka S Gooneratne; Alena Y Z Edwards; Chen Zhou; Norma Cuellar; Michael A Grandner; Jeffrey S Barrett
Journal:  J Pineal Res       Date:  2012-02-21       Impact factor: 13.007

Review 5.  Putting cancer to sleep at night: the neuroendocrine/circadian melatonin signal.

Authors:  David E Blask; Robert T Dauchy; Leonard A Sauer
Journal:  Endocrine       Date:  2005-07       Impact factor: 3.633

6.  Melatonin fails to protect against long-term MPTP-induced dopamine depletion in mouse striatum.

Authors:  C J van der Schyf; K Castagnoli; S Palmer; L Hazelwood; N Castagnoli
Journal:  Neurotox Res       Date:  2000-04       Impact factor: 3.911

Review 7.  Clinical pharmacokinetics of antioxidants and their impact on systemic oxidative stress.

Authors:  Edzard Schwedhelm; Renke Maas; Raphael Troost; Rainer H Böger
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

Review 8.  Melatonin: possible implications for the postoperative and critically ill patient.

Authors:  Richard S Bourne; Gary H Mills
Journal:  Intensive Care Med       Date:  2006-02-14       Impact factor: 17.440

9.  Pharmacokinetics of Melatonin: The Missing Link in Clinical Efficacy?

Authors:  Lars Peter Holst Andersen; Ismail Gögenur; Jacob Rosenberg; Russel J Reiter
Journal:  Clin Pharmacokinet       Date:  2016-09       Impact factor: 6.447

10.  Randomized phase II trial of high-dose melatonin and radiation therapy for RPA class 2 patients with brain metastases (RTOG 0119).

Authors:  Lawrence Berk; Brian Berkey; Tyvin Rich; William Hrushesky; David Blask; Michael Gallagher; Mahesh Kudrimoti; Ronald C McGarry; John Suh; Minesh Mehta
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-04-06       Impact factor: 7.038
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.